Synthesis and evaluation of antioxidant activity of novel 3,5-disubstituted-2-pyrazolines  by Kumar, Akshay et al.
Bulletin of Faculty of Pharmacy, Cairo University (2013) 51, 167–173Cairo University
Bulletin of Faculty of Pharmacy, Cairo University
www.elsevier.com/locate/bfopcu
www.sciencedirect.comORIGINAL ARTICLESynthesis and evaluation of antioxidant activity of novel
3,5-disubstituted-2-pyrazolinesAkshay Kumar a, Bhat G. Varadaraj a, Rajeev K. Singla b,*a Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal University,
Manipal 576104, Karnataka, India
b Division of Biotechnology, Netaji Subhas Institute of Technology, Azad Hind Fauz Marg, Sector-3, Dwarka,
110078 New Delhi, IndiaReceived 27 November 2011; accepted 20 April 2013
Available online 4 June 2013*
E
Pe
U
11
OKEYWORDS
3,5-Disubstituted-2-pyrazo-
line;
Antioxidant;
Reactive oxygen speciesCorresponding author. Tel.
-mail address: rajeevsingla26
er review under responsibi
niversity.
Production an
10-0931 ª 2013 Production
pen access under CC BY-NC-ND l: +91 98
@gmail.
lity of F
d hostin
and hosti
httpicense.Abstract Driven by the increased demand of pyrazolines exhibiting biological activities like anti-
oxidant, anti-inﬂammatory, antidepressant, antimicrobial, antitumor, and antitubercular drug
activity as a stable fragment in biological moieties, lead us to synthesize 2-pyrazolines by the con-
densation of various substituted chalcones and hydrazine hydrate in the presence of ethanol. The
structure of the synthesized molecules was conﬁrmed on the basis of physical data and extensive
spectral studies. All the 13 compounds have been screened for antioxidant activity using DPPH rad-
ical scavenging method, NO scavenging assay, superoxide radical scavenging assay and hydrogen
peroxide radical scavenging assay. All the compounds showed good free radical scavenging activity
which is comparable to that of the standard ascorbic acid, out of which ATP-1, ATP-2 and ATP-3
come out to be the best molecules with an IC50 less than 40 mcg/ml. The results indicated that
2-pyrazolines could be the potential candidates eliciting antioxidant activity, and further studies
can be conducted using molecular modeling tools for designing 2-pyrazolines having better activity.
ª 2013 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
Open access under CC BY-NC-ND license.1. Introduction
Small ring heterocycles containing nitrogen, sulfur and oxygen
have been under investigation for a long time because of their186 03719.
com (R.K. Singla).
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://dx.doi.org/10.1016/j.bfopcu.201important medicinal properties.1 Also, 2-pyrazolines have been
reported to possess a variety of signiﬁcant and diverse pharma-
cological activities such as antibacterial,2–4 antifungal,5,6 anti-
viral,7 antitubercular,8,9 antidepressant,10,11 antiamoebic,12,13
anti-inﬂammatory,14 anticonvulsant,15 analgesic,16 antican-
cer17 and antioxidant activities.
The reactive oxygen species, which include superoxide an-
ions (O2
), hydrogen peroxide (H2O2) and hydroxyl radicals
(OH), and Lipid peroxidation, which involves a series of free
radical mediated chain reactions processes, are associated with
several types of biological damage. Sodium nitroprusside, a
vasodilator drug induces oxidative brain injury, which is
actually mediated by the hydroxyl radicals generated by ironaculty of Pharmacy, Cairo University.
3.04.002
Figure 1 General structure of 3-[(4-hydroxy-3-methoxy)phenyl]-
5-phenyl/substituted phenyl-2-pyrazoline derivatives.
Figure 2 Schematic synthesis of 3,5-disubstituted-2-pyrazolines.
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glutathione and other thiols which signiﬁcantly reduce sodium
nitroprusside and other reactive oxygen species. But for the
neurodegenerative disorders, supplementation with external
antioxidant agents is of need. But unfortunately, the clinically
effective antioxidant drugs are scarce. Therefore much atten-
tion has been focused on the use of synthetic antioxidants to in-
hibit lipid peroxidation and to protect from damage due to free
radicals.18
2-Pyrazolines seem to be the most frequently studied pyraz-
oline type compounds. After the pioneering work of Fischer
and Kno¨venagel in the late nineteenth century, the reaction
of a,b-unsaturated aldehydes and ketones and then with
hydrazines became one of the most popular methods for the
preparation of 2-pyrazolines. 2-pyrazolines have potential
antioxidative effects, capable of preventing oxidative damage
as well as clastogenic effects.19,20 As a result, numerous substi-
tuted 2-pyrazolines have been synthesized. In light of these
ﬁndings, it was felt worthwhile to synthesize some new 2-pyr-
azoline derivatives and evaluate them for their antioxidant
potential.
So the current paper deals with the synthesis of novel 2-pyr-
azolines (Fig. 1) and statistical analysis of their anti oxidant
potential.
2. Materials and Methods
2.1. Drugs and chemicals
Reactants and reagents for the synthesis of molecules (ATP
01–13) and for the evaluation of antioxidant activity were pro-
cured from Sigma–Aldrich Ltd. All the drugs and chemicals
except the test compounds were dissolved or diluted in distilled
water and used for the experimentation purpose. ATP 01–13
were dissolved in 100% DMSO and dilutions were made with
distilled water so that the ﬁnal concentration of DMSO did not
exceed (0.1% v/v).
2.2. Instrumentation
Melting points were determined using open capillary tube in
Toshniwal melting point apparatus and are uncorrected. UV
spectra were recorded on Shimadzu UV 1650. IR spectra were
recorded on Shimadzu FTIR-8310 using KBr pellets.
1H-NMR spectra were recorded on AMX 400 at 200 MHz
using tetramethylsilane (TMS) as the internal standard and
DMSO as solvent, collected from the Indian Institute of
Science(IISc), India. LC-ESI-MS were recorded using
Shimadzu LC-ESI-MS at Manipal Accunova, Manipal. Rota
evaporator and UV chamber from Servewell InstrumentsPvt. Ltd. The chemical shifts were expressed in part per million
(ppm) downﬁeld from the internal standard; the coupling
constants are in Hz, and signals are quoted as s (singlet), d
(doublet), t (triplet), q (quartet), or m (multiplet). The purity
of the compounds was checked by TLC using Merck pre-
coated silica gel GF aluminum plates and ethyl acetate:
chloroform (15:85) as solvent system.
2.3. General procedure for synthesis of chalcone derivatives
(Fig. 2)
A mixture of 1-(4-hydroxy-3-methoxyphenyl)ethanone (0.01
mol) and sodium hydroxide (20%, 5 ml) in methanol (5–10 ml)
was added to the appropriate (un)substituted benzaldehyde
(0.01 mol). After complete addition, the reaction mixture was
stirred for 24 h at room temperature, with regular monitoring
by TLC. This mixture was then poured into crushed ice
(300 gm) and was neutralized with dil. HCl, resulting in the
precipitation of chalcone. The precipitated solid was then
ﬁltered, washed and dried in a vacuum desiccator. Product
was recrystallized using ethanol–water gradient. The purity of
the each compound was checked by TLC using n-hexane: ethyl
acetate (7:3).21
2.4. Procedure for synthesis of chalcone from 3-OH
benzaldehyde, iii10 (Fig. 2)
A mixture of 1-(4-hydroxy-3-methoxyphenyl)ethanone
(0.01 mol) and sodium hydroxide (20%, 5 ml) in methanol
(5–10 ml) was added to the appropriate 3-hydroxybenzalde-
hyde (0.01 mol). After complete addition, the reaction mixture
Figure 3 DPPH radical scavenging assay results of novel 3,5-disubstituted-2-pyrazolines.
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into crushed ice (300 ml) and was neutralized with dil. HCl,
resulted in the precipitation of (E)-1-(4-hydroxy-3-methoxy-
phenyl)-3-(3-hydroxyphenyl)prop-2-en-1-one. The precipitated
solid was ﬁltered, washed and dried in a vacuum desiccator.
Product was recrystallized using ethanol–water gradient. The
purity of the each compound was checked by TLC using
n-hexane: ethyl acetate (7:3).22
2.5. Procedure for synthesis of 3-[(4-hydroxy-3-methoxy)
phenyl]-5-phenyl/substituted phenyl-2-pyrazoline derivatives
(ATP 01–13) (Fig. 2)
A mixture of chalcone (0.001 mol) and hydrazine hydrate
(99–100%, 0.003 mol) in methanol (5–10 ml) was reﬂuxed for
2–3 h, followed by solvent evaporation using rota evaporator to
yield solid product. The solid compound thus obtained was then
ﬁltered andwashedwithwater followed bymethanol.White crys-
tallinepowderwasobtained.Thepurityof the compounds (Fig. 3)
was checked by TLC using n-hexane:ethyl acetate (9:1).
2.5.1. 3-[(4-Hydroxy-3-methoxy) phenyl]-5-phenyl-2-
pyrazoline (ATP-1)
Molecular formula C16H16N2O2, Mol wt. 268, % yield
64.33, M. Pt. 170, UV (nm): 305.60, 208.60, FT-IR (KBr
disc): 3331 (Ar O–H); 3080, 3032 (Ar–H); 2956, 2926,
2879 (C–H); 1645 (C‚N); 1599, 1568, 1514, 1456 (Ar
C‚C); 1203 (Ar C–OH), 1H-NMR: 2.80–2.74 (dd, 1H,
CHHa), 3.40–3.29 (dd, 1H, CHbH), 3.78 (s, 3H, OCH3), 4.73
(t, 1H, CHAr), 6.75 (d, 1H, NH), 7.23–6.95 (m, 7H, Ar), 9.2
(s, 1H, ArOH).
2.5.2. 3-[(4-Hydroxy-3-methoxy) phenyl]-5-(4-methylphenyl)-
2-pyrazoline (ATP-2)
Molecular formula C17H18N2O2, Mol wt. 282, % yield 55.50,
M. Pt. 149, UV (nm): 306.60, 213.60, FT-IR (KBr disc):
3346.61 (Ar O–H); 3080, 3049 (Ar–H); 2962, 2924, 2879,
2850 (C–H); 1600, 1562, 1510, 1458 (Ar C‚C); 1211 (Ar C–
OH), 1H-NMR: 2.28 (s, 3H, CH3), 2.80–2.74 (dd, 1H, CHHa),
3.40–3.29 (dd, 1H, CHbH), 3.78 (s, 3H, OCH3), 4.73 (t, 1H,
CHAr), 6.75 (d, 1H, NH), 7.23–6.95 (m, 7H, Ar), 9.2 (s, 1H,
ArOH), 3.6 (d, 3H, Ar–CH3).2.5.3. 3-[(4-Hydroxy-3-methoxy) phenyl]-5-(3-methylphenyl)-
2-pyrazoline (ATP-3)
Molecular formula C17H18N2O2, Mol wt. 282, % yield 35.33,
M. Pt. 123, UV (nm): 306.60, 211.00, FT-IR (KBr disc):
3335 (Ar O–H); 3086, 3051 (Ar–H); 2955, 2922, 2856 (C–H);
1599, 1575, 1514, 1458 (Ar C‚C); 1205 (Ar C–OH), 1H-
NMR: 2.80–2.74 (dd, 1H, Jab = 16.0 Hz, Jax= 8.0 Hz,
CHa); 3.40–3.29 (dd, 1H, Jab = 16.0 Hz, Jbx= 8.0 Hz,
CHb); 3.78 (s, 3H, OCH3); 4.73 (t, 1H, J = 10 Hz CHAr);
6.75 (d, 1H, NH); 7.23–6.95 (m, 7H, Ar); 9.2 (s, 1H, ArOH),
MS: [M+] 282; [M+CH3]ﬁ 267; [M+OCH3]ﬁ 251.
2.5.4. 3-[(4-Hydroxy-3-methoxy) phenyl]-5-(4-bromophenyl)-
2-pyrazoline (ATP-4)
Molecular formula C16H15BrN2O2, Mol wt. 347, % yield
66.16, M. Pt. 146, UV (nm): 307.60, 208.40, FT-IR (KBr disc):
3340 (Ar O–H); 3097, 3055 (Ar–H); 2953, 2922, 2850 (C–H);
1600, 1573, 1512, 1460 (Ar C‚C); 1205 (Ar C–OH); 545
(Ar–C–Br); 1H-NMR: 2.80–2.74 (dd, 1H, CHHa), 3.40–3.29
(dd, 1H, CHbH), 3.78 (s, 3H, OCH3), 4.73 (t, 1H, CHAr),
6.75 (d, 1H, NH), 7.23–6.95 (m, 7H, Ar), 9.2 (s, 1H, ArOH),
3.9 (s, 1H, Ar–CH–Br).
2.5.5. 3-[(4-Hydroxy-3-methoxy) phenyl]-5-(3-bromophenyl)-
2-pyrazoline (ATP-5)
Molecular formula C16H15BrN2O2, Mol wt. 347, % yield 37.66,
M. Pt. 120, UV (nm): 306.60, 204.60, FT-IR (KBr disc): 3333 (Ar
O–H); 3082, 3057 (Ar–H); 2960, 2924, 2852 (C–H); 1566, 1512,
1456 (Ar C‚C); 1205 (Ar C–OH); 550 (Ar–C–Br), 1H-NMR:
2.80–2.74 (dd, 1H, CHHa), 3.40–3.29 (dd, 1H, CHbH), 3.78 (s,
3H, OCH3), 4.73 (t, 1H, CHAr), 6.75 (d, 1H, NH), 7.23–6.95
(m, 7H, Ar), 9.2 (s, 1H, ArOH), 4.2 (s, 1H, Ar–CH–Br).
2.5.6. 3-[(4-Hydroxy-3-methoxy) phenyl]-5-(4-chlorophenyl)-
2-pyrazoline (ATP-6)
Molecular formula C16H15ClN2O2, Mol wt. 302, %
yield 68.66, M. Pt. 154, UV (nm): 306.40, 217.40, FT-IR
(KBr disc): 3340 (Ar O–H); 2924 (C–H); 1597, 1575, 1512,
1487 (Ar C‚CC), 1H-NMR: 2.80–2.74 (dd, 1H, CHHa),
3.40–3.29 (dd, 1H, CHbH), 3.78 (s, 3H, OCH3), 4.73 (t, 1H,
CHAr), 6.75 (d, 1H, NH), 7.23–6.95 (m, 7H, Ar), 9.2 (s, 1H,
ArOH).
Figure 4 Nitric oxide scavenging assay results of novel 3,5-disubstituted-2-pyrazolines.
Figure 5 Superoxide scavenging assay results of novel 3,5-disubstituted-2-pyrazolines.
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2-pyrazoline (ATP-7)
Molecular formula C16H15ClN2O2, Mol wt. 302, % yield
40.00, M. Pt. 138, UV (nm): 306.00, 211.00, FT-IR (KBr disc):
3331 (Ar O–H); 3080 (Ar–H); 2960, 2926, 2862 (C–H); 1597,
1570, 1512, 1460 (Ar C‚CC); 1203 (Ar C–OH); 645
(Ar–C–Cl), MS: [M+]ﬁ 302; [M+CH3]ﬁ 287;
[M+OCH3]ﬁ 271.
2.5.8. 3-[(4-Hydroxy-3-methoxy)phenyl]- 5-(4-
methoxyphenyl)-2-pyrazoline(ATP-8)
Molecular formula C17H18N2O3, Mol wt. 298, % yield 81.66,
M. Pt. 136, UV (nm): 306.40, 208.40; FT-IR (KBr disc):
3320 (Ar–O–H), 3000, 2870 (C–H), 1600, 1525 (Ar C‚CC),
1200 (Ar C–OH), 1H-NMR: 2.7–3.4 (dd, 2H, pyrazoline
CH2), 3.71 (s, 3H, m-OCH3), 3.78 (s, 3H, p-OCH3), 4.79 (t,
1H, J = 10.4 Hz, CHAr), 6.5 (d, 1H, NH), 6.8–8.5 (m, 7H,
Ar), 9.2 (s, 1H, ArOH).
2.5.9. 3-[(4-Hydroxy-3-methoxy)phenyl]-5-(3-
methoxyphenyl)-2-pyrazoline (ATP-9)
Molecular formula C17H18N2O3, Mol wt. 298, % yield 87.00,
M. Pt. 164, UV (nm): 306.80, 203.40; FT-IR (KBr disc):
3325 (Ar–O–H), 2928, 2847 (C–H), 1599, 1514 (Ar C‚CC),
1195 (Ar C–OH), 1H-NMR: 2.81–2.74 (dd, 1H, Jax= 5.6 Hz,
Jab= 16 Hz, Ha), 3.41–3.29 (dd, 1H, Jbx = 5.6 Hz,Jab = 16 Hz, Hb), 3.73 (s, 3H, OCH3[A]), 3.77 (s, 3H,
OCH3[B]), 4.74 (t, 1H, J = 10.4 Hz, CHAr), 6.75 (d, 1H,
NH), 7.25–6.79 (m, 7H, Ar), 9.2 (s, 1H, ArOH); MS:
[M+]ﬁ 298; [M+CH3]ﬁ 283; [M+OCH3]ﬁ 267.
2.5.10. 3-[(4-Hydroxy-3-methoxy)phenyl]-5-(3-
hydroxyphenyl)-2-pyrazoline (ATP-10)
Molecular formula C16H16N2O3, Mol wt. 284, % yield 40.33,
M. Pt. 222, UV (nm): 306.80, 206.60; FT-IR (KBr disc):
3300 (Ar O–H); 3100, 3050 (Ar–H); 2950, 2906 (C–H); 1670
(C‚CN); 1599, 1514, 1456 (Ar C‚CC); 1215 (Ar C–OH),
1245 (Asymmetric C–O–C stretch), 1043 (symmetric C–O–C
stretch); 1H-NMR: 2.3–3.2 (dd, 2H, Pyrazoline CH2), 3.54 (s,
3H, m-OCH3), 4.44 (t, 1H, CH–Ar), 6.2–7.5(m, 7H, Ar–H),
5.8 (d, 1H, NH), 9.1 (s, 1H, m-Ar-OH), 9.3 (s, 1H, p-Ar-OH).
2.5.11. 3-[(4-Hydroxy-3-methoxy)phenyl]-5-(4-nitrophenyl)-
2-pyrazoline (ATP-11)
Molecular formula C16H15N3O4, Mol wt. 313, % yield 34.00,
M. Pt. 177, UV (nm): 306.80, 206.20, FT-IR (KBr disc):
3331 (Ar O–H); 3080, 3032 (Ar–H); 2956, 2926, 2879 (C–H);
1645 (C‚CN); 1599, 1514, 1456 (Ar C‚CC); 1203 (Ar
C–OH), 1250 (Asymmetric C–O–C stretch), 1048 (symmetric
C–O–C stretch), 1568 [Asymmetric (ArNO2) (N‚CO)2
stretch], 1345 [symmetric (ArNO2) (N‚CO)2 stretch],
850 (C–N stretch for ArNO2);
1H-NMR: 2.5–3.5 (dd, 2H,
Figure 6 Hydrogen peroxide scavenging assay results of novel 3,5-disubstituted-2-pyrazolines.
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6.5–7.7 (m, 7H, Ar–H), 6.3 (d, 1H, NH), 9.3 (s, 1H, p-Ar-OH).
2.5.12. 3-[(4-Hydroxy-3-methoxy)phenyl]-5-(3,4-
dimethoxyphenyl)-2-pyrazoline (ATP-12)
Molecular formula C17H20N2O4, Mol wt. 329, % yield 17.33,
M. Pt. 144, UV (nm): 286.80, 211.80; FT-IR (KBr disc):
3392, 3315 (Ar O–H); 2926 (C–H); 1577, 1512, 1456 (Ar
C‚CC); 1247 (Asymmetric C–O–C stretch); 1040 (symmetric
C–O–C stretch); MS: [M+]ﬁ 329; [M+CH3]ﬁ 314;
[M+OCH3]ﬁ 298.
2.5.13. 3-[(4-Hydroxy-3-methoxy)phenyl]-5-(3-hydroxy-4-
methoxyphenyl)-2-pyrazoline (ATP-13)
Molecular formula C17H18N2O4, Mol wt. 314, % yield 58.66,
M. Pt. 192, UV (nm): 286.40, 207.00; FT-IR (KBr disc):
3392, 3315 (Ar O–H); 2926 (C–H); 1577, 1512, 1456 (Ar
C‚CC); 1H-NMR: 2.7–3.4 (dd, 2H, Pyrazoline CH2), 3.65
(s, 3H, p-OCH3), 3.83(s, 3H, m-OCH3),4.63(t, 1H, CH–Ar),
6.8–7.5(m, 7H, Ar–H), 6.6 (d, 1H, NH), 9.1 (s, 1H,
m-Ar-OH), 9.4 (s, 1H, p-Ar-OH).
2.6. Evaluation of antioxidant activity
2.6.1. Diphenylpicrylhydrazyl radical assay method (DPPH
method)
The assay was carried out in a 96 well microtiter plate. To
100 ll of DPPH solution, 100 ll of each of the test sample
or the standard drug was added separately in wells of the
microtiter plate. The ﬁnal concentrations in the wells for test
and standard solutions were 500–4 lg. The plates were incu-
bated at 37 C for 20 min and the absorbance of each solution
was measured at 540 nm, using ELISA microtiter plate reader.
The experiment was performed in triplicate and% scavenging
activity was calculated using the formula given below. IC50
(Inhibitory concentration) is the concentration of the sample
required to scavenge 50% of DPPH free radicals and it was
calculated from the graph, % scavenging vs. concentration.23
% Scavenging ¼ Control Test
Control
 1002.6.2. Nitric oxide scavenging assay
The reaction mixture (3 ml) containing sodium nitroprusside
(10 mM, 2 ml), phosphate buffered saline (PBS, 0.5 ml) and0.5 ml of each test sample in DMSO was incubated separately
at 25 C for 150 min. After incubation, 50 ll of the reaction
mixture containing nitrate was removed and 100 ll of sulfanil-
amide reagent was added and allowed to stand for 5 min for
completion of diazotization, then 100 ll of NEDD was added
and allowed to stand for 30 min in diffused light at room tem-
perature. The absorbance of these solutions was measured at
540 nm using ELISA microtiter plate reader. The experiment
was performed in triplicate and % scavenging activity was
calculated using the formula given below. IC50 (Inhibitory
concentration) is the concentration of the sample required to
scavenge 50% of nitric acid and it was calculated from the
graph, % scavenging vs. concentration.24,25
% Scavenging ¼ Control Test
Control
 100
2.6.3. Superoxide scavenging assay
To 0.3 ml of various fractions of test and standard sol. in
DMSO, 1 ml alkaline DMSO and 0.1 ml NBT were added.
The absorbance was measured at 560 nm. The experiment
was performed in triplicate.26,27
% Scavenging ¼ Test Control
Test
 1002.6.4. Hydrogen peroxide scavenging assay
A solution of hydrogen peroxide (20 mM) was prepared in
phosphate buffer saline (PBS) (pH 7.4). Various fractions of
test and standard solution in DMSO were added to 2 ml of
hydrogen peroxide solution in PBS. After 10 min, the absor-
bance was measured at 230 nm.28,29
% Scavenging ¼ Test Control
Test
 1003. Results and discussion
In the present study, chalcones iii were synthesized by
condensing various (un)substituted benzaldehydes i with
3-methoxy-4-hydroxyacetophenone ii. Reﬂuxing chalcones iii
with hydrazine hydrate iv for 2–3 h in ethanol yielded
the target compounds 2-pyrazoline derivatives v. All the
13 novel compounds were subjected to their structural
Figure 7 Mean antioxidant activity of novel 3,5-disubstituted-2-pyrazolines.
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proton NMR and MS). 3,5-Disubstituted-2-pyrazolines have
shown characteristic absorbance within the range of 305–
307 nm when observed under UV spectroscopy. General vibra-
tional frequencies of the parent molecule in the IR study were
3330 for the hydroxyl group in the aromatic ring, 3086, 3051
for the aromatic hydrogens, 2800–3000 for the C–H, 1458–
1599 for the aromatic C‚C stretching, 1200 for Ar–C–OH.
Compounds had shown their characteristic peaks according
to the substituents like 545 cm1 for the bromine substitutions
in ATP-4 and ATP-5, 645 cm1 for aromatic chloro group in
ATP-6 and ATP-7, 1568 and 1345 for the nitro substation in
ATP-11 and so on. In the proton NMR spectra of the general-
ized parent molecule, a doublet of doublet peak at 2.28–2.74
for the methylene of pyrazoline, a singlet at 3.78 for the meth-
oxy group, multiplet within the range of 6.5–8.0 for the aro-
matic hydrogens, a doublet at 6.75 for amino of pyrazoline
and a singlet at 9.2 or 9.3 for the aromatic hydroxyl group
were seen. Compounds had shown their characteristic peaks
according to the substituents like a triplet at 4.73 for the
methyl substitution at aromatic ring in ATP-2 and ATP-3
and so on.
All the 13 novel molecules were subject for their evaluation
of antioxidant proﬁle using four models DPPH radical scaveng-
ing assay method (Fig. 3), nitric oxide scavenging assay method
(Fig. 4), superoxide scavenging assay method (Fig. 5) and
hydrogen peroxide scavenging assay (Fig. 6), while the mean
antioxidant activity of these molecules were represented by
Fig. 7. All the compounds were shown to have excellent antiox-
idant activity when compared with standard ascorbic acid.
After careful evaluation of DPPH assay, NO scavenging, super-
oxide scavenging and hydrogen peroxide scavenging assay re-
sults, it reveals that ATP-1, ATP-2 and ATP-3 have shown
the potential antioxidant activity out of which ATP-2 is the best
one when compared with ascorbic acid. It signiﬁes the role of
steric as well as electron releasing group CH3 at the meta substi-
tuted group of 2-pyrazoline for the inhibition of free radicals.
Electron withdrawing groups and high electron releasing
groups like methoxy are not facilitators of free radical inhibi-
tion. Electron withdrawing groups reduce the efﬁciency of
hydrogen release from the amino group of pyrazoline, so if hal-
ogens were the substituents on the 3-phenyl of pyrazoline, anti-
oxidant activity greatly reduced revealing the inappropriateness
of halogen in antioxidants. Moreover the nitro group contain-
ing molecule ATP-11 has shown the poor scavenging results
for the nitric oxide scavenging assay revealing the inability ofmolecules(having nitro group) to scavenge nitric oxide radicals
in the body. Hydroxyl and methoxy group substituents induc-
ing the resonance thereby stabilize the molecules, so the mole-
cules with above substituents have less antioxidant capacity.
Least activity was observed with the hydroxyl andmethoxy sub-
stitutions at the 3-phenyl of 2-pyrazoline, so these substitutions
are not recommended further for the antioxidant molecules.
4. Conclusion
We reported the synthesis and evaluation of antioxidant activity
of 3,5-disubstituted-2-pyrazoline analogs. The results were al-
most comparable to standard ascorbic acid. The ﬁndings are
highly signiﬁcant. It is proposed to prevent the use of electron
withdrawing groups in the 3,5-disubstituted-2-pyrazoline ana-
logs if aimed to be having a potential antioxidant. Based on
the data of the present study, it is very difﬁcult to suggest any
possible mechanism for the antioxidant effects of the deriva-
tives, as the present study is purely a preliminary investigation.
But still the results of this study will provide useful information
for the design of novel molecules as antioxidant agents.
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